A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2- early breast cancer.

Sci Rep · 2017 · PMC5368569 · PMID 28350001

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

Finally, the expression levels of six prognostic genes, UBE2C, TOP2A, RRM2, FOXM1, MKI67 , and BTN3A2 , which are either significant or marginally significant for DMFS in LN−, HR+/HER2− breast cancer, were selected to develop a novel prognostic algorithm to predict the risk of distant metastasis in HR+/HER2− early breast cancer ( Table 4 ).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.